BioNTech SE

BNTXNasdaq Germany Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$23.530 B

$93.67 +2.72%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

251,204,366

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#5BiogenBIIB$30.7B
#6ModernaMRNA$23.6B
#7BioNTech SEBNTX$23.5B
#8Neurocrine BiosciencesNBIX$16.6B
#9ExelixisEXEL$13.4B

Where these numbers come from

Share counts and financials for BioNTech SE are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.